[ORGANIZATION]
epcoritamab
Featured in 1 tracked story · first seen
Also covered in
-
AbbVie and Genmab report 51% reduction in lymphoma progression risk
[BUSINESS] · 4 sources ·
[ORGANIZATION]
Featured in 1 tracked story · first seen
[BUSINESS] · 4 sources ·